Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. - Wikidata - wikimedia - TriplyDB

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

http://www.wikidata.org/entity/Q30560444

about

Current trends in the surgical management and treatment of adult glioblastoma Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography.Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer.Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells Survival in glioblastoma: a review on the impact of treatment modalities.The value of extent of resection of glioblastomas: clinical evidence and current approach.Strategy of Surgical Resection for Glioma Based on Intraoperative Functional Mapping and Monitoring.Surgical complications following malignant brain tumor surgery: An analysis of 2002-2011 data.Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Label-free delineation of brain tumors by coherent anti-Stokes Raman scattering microscopy in an orthotopic mouse model and human glioblastoma Assessment and treatment relevance in elderly glioblastoma patients.The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study.The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible.Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.Quantitative MRI for analysis of peritumoral edema in malignant gliomas Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial Glioblastoma recurrence patterns near neural stem cell regions.Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery Network Plasticity and Intraoperative Mapping for Personalized Multimodal Management of Diffuse Low-Grade Gliomas.5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Active dendritic cell immunotherapy for glioblastoma: Current status and challenges.Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.Intraoperative imaging techniques for glioma surgery.Investigational new drugs for brain cancer.Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.Nanotherapeutic systems for local treatment of brain tumors.Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.Impact of removed tumor volume and location on patient outcome in glioblastoma.Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012.Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes

P2860

Q26799854-409F3BEF-3DD8-4990-857C-5996FB88F4A2 Q27327216-8F7D8A21-5FB3-4173-B925-5B131E807CEA Q27330583-FFC19935-06EA-4498-B786-B9CDBBD945DD Q28078505-9BC200F6-7DBB-41FB-8AB2-C8E41AF4B9FC Q28833661-8D0418B3-DA9D-4A54-ABA9-7A6799E8E4F5 Q30251810-BCB8C801-C9F4-4EDC-B543-1359139BEB33 Q30873962-5D62BB17-11B5-4A92-B90F-24C3597B6C25 Q30981108-1A4E1700-F467-41A8-96B1-E91D3D987023 Q31029088-4B6E3E15-96FB-4012-9D02-32047F09E818 Q33586021-2368A04B-DA61-4BB4-8CA6-2FC54C5CE96A Q34159062-A92CD430-ED38-4E4E-8087-FB9DA6122152 Q34359650-C7FAAAD3-D90A-4A7A-9BD2-CB9AD078DB95 Q35038271-6B3C44DC-B9B2-47EF-A06A-7E6A73BA6207 Q35675842-DB3A01FE-D404-441C-A6B6-BADC419AB4F7 Q35925839-5E3A6B1A-D7CE-4F6B-8ABE-1A0E0C1A4FD3 Q35967155-66CFC56C-45A2-4942-BFA1-FAF69798F0AC Q36082516-7695F55F-6932-4A36-AC19-B4AC6CCAAC42 Q36380888-17107A92-2806-44D1-A384-71CC7E3213DB Q36540727-4F9F6BD4-7F0C-4B3D-9948-07728924C911 Q36705933-BAA20D8C-F80B-45DC-9FF9-47FB2585B5D1 Q36871199-58715A7A-0FDD-4759-BE1B-5BCFEA5D96EE Q36889298-99233457-62C0-4619-BC8F-4E159CA412E6 Q37614559-8BE13AB2-8161-4B59-9112-F536903A171A Q37720272-311C06F4-AE9B-448A-B2D1-4E98E30F8D0A Q38255481-B995C1F5-56A1-4480-A5FD-C529065D7B7A Q38301084-35F12514-F716-4235-B8A1-29D554828081 Q38411351-93ADED4B-FA46-49CA-B2B4-087143DAE776 Q38644470-A083CB81-DF97-434C-BE72-DF46D25B96DE Q38832510-B4BBCE35-36B8-4AE4-BCC3-258302C02E6A Q38834470-257D91C3-DDE5-4551-A2C9-28D582C1341A Q39264053-449C0A55-C0CD-427C-A1AD-8A6530865A44 Q39273311-C876D460-37C6-4DDD-91A0-74813F10D202 Q39330269-505E58C2-0D4D-448C-BB87-46F8B49F9514 Q39417263-07FB0E51-FB3D-46BF-9D24-B9B5ED01379B Q39420029-968AD08C-FE86-4553-8DC1-7862292837D6 Q39607166-62FF0E86-156B-47F6-8715-09E892828A70 Q40093333-8C0B7982-3539-4E98-8593-3A410A53FC3E Q41000308-0592F1C2-A659-464D-96CF-489177E2AC63 Q41041048-8A2F27CB-A853-4B58-B089-2A2B3B76FA48 Q41059446-E67D49EB-6E6E-4752-9A82-A7A85DC7835F

P2860

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

http://www.wikidata.org/entity/Q30560444

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Establishing percent resection ...... sed intracranial glioblastoma.

@ast

Establishing percent resection ...... sed intracranial glioblastoma.

@en

type

label

Establishing percent resection ...... sed intracranial glioblastoma.

@ast

Establishing percent resection ...... sed intracranial glioblastoma.

@en

prefLabel

Establishing percent resection ...... sed intracranial glioblastoma.

@ast

Establishing percent resection ...... sed intracranial glioblastoma.

@en

P1433

Q30560444-9F48C8DA-3437-4568-9B6E-AE49E7812E11

P1476

Q30560444-29EBE8DA-FC47-4253-B616-6500A6780139

P2093

Q30560444-01DFE603-383D-490A-9697-8CD61226EC57

Q30560444-031864DB-C36D-457F-AEF5-4A0B933F736B

Q30560444-08254940-8905-4251-B9D1-9F7770C41A07

Q30560444-15220F4A-5BAD-4550-AEE7-0E103A975599

Q30560444-3744E5A1-4F8D-4BA3-9C99-02B9E6BC8533

Q30560444-46F6E3D1-8244-416D-86A3-BA476A5B5F35

Q30560444-5ABE70EB-0774-4938-9AAE-E6008E1AC309

Q30560444-93659ED4-960C-4CFF-89AD-C54DA0259CDE

Q30560444-B34D0C76-954D-4E23-A995-A94AA42C6D1B

Q30560444-C0BD57BC-3F64-4337-9402-7DAB2CEEB598

P2860

Q30560444-035D4B54-43E0-4DB5-A28F-4E4FC0AADA5E

Q30560444-06FA52E7-BC8F-4192-A7C8-4924854B0B91

Q30560444-1E30F36B-67A7-4C6D-B8C7-4B5AC5F05743

Q30560444-24AC79CB-EA2B-45C2-81C8-0A59F8083973

Q30560444-2C5D8FFC-B8BC-4D81-88FE-5B9D2FC2E0DD

Q30560444-3A65F896-0756-4667-AA8B-861CB5372309

Q30560444-4411059F-BD9D-4D38-800A-274D9663C509

Q30560444-4A7A6C39-1E1B-433E-A50C-B98B28F40223

Q30560444-4FDCD4D7-14F4-44F6-85E6-E6A16316B489

Q30560444-53CAAB13-417B-417C-A892-1970FC09657A

P304

Q30560444-425E1CA3-9AEC-4C06-BAFD-941545342A2B

P31

Q30560444-06F08B8A-0890-41E1-B6BE-C6E7BEE58B8C

P356

Q30560444-D3B429D4-A701-404C-AE41-32EA0D6E1FFD

P433

Q30560444-8FF248A9-F176-4556-9319-143E0323F103

P478

Q30560444-A52596D5-4F9E-4868-8CE2-748847524780

P50

Q30560444-3F26FAAF-DB8F-46E8-9A77-F7AAF8A06966

Q30560444-7C267587-BD2E-43EA-B321-196D07E5728E

P577

Q30560444-BB06F1FC-7E36-46D5-B8C6-C7A61BEB3A58

P5875

Q30560444-9406F7EA-6C31-44A7-982D-F9005EBEED8D

P698

Q30560444-044AD864-E246-4578-B694-50BEB550B8C4

P932

Q30560444-0C6D832B-DB46-417D-B489-EF47B25132DF

P356

P1433

P1476

Establishing percent resection ...... sed intracranial glioblastoma.

@en

P2093

Aly Ibrahim

http://www.w3.org/2001/XMLSchema#string

Gary L Gallia

http://www.w3.org/2001/XMLSchema#string

Henry Brem

http://www.w3.org/2001/XMLSchema#string

Ignacio Jusue-Torres

http://www.w3.org/2001/XMLSchema#string

Jaishri Blakeley

http://www.w3.org/2001/XMLSchema#string

Jon D Weingart

http://www.w3.org/2001/XMLSchema#string

Kaisorn L Chaichana

http://www.w3.org/2001/XMLSchema#string

Luis Gomez

http://www.w3.org/2001/XMLSchema#string

Maria Pascual-Gallego

http://www.w3.org/2001/XMLSchema#string

Marta Hernandez-Hermann

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

The human subventricular zone: a source of new cells and a potential source of brain tumors

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.

Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

Intraoperative stimulation techniques for functional pathway preservation and glioma resection.

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article

P304

113-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOT137

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Olivi

Alfredo Quinones-Hinojosa

P577

2013-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258958368

http://www.w3.org/2001/XMLSchema#string

P698

24285550

http://www.w3.org/2001/XMLSchema#string

P932

3870832

http://www.w3.org/2001/XMLSchema#string